$ITMN Recent News 6 stocks to watch 3:25 p.m. May 29,

New Post Public Reply Private Reply Replies (0) Message Board

Jun 3, 2014 at 9:34 AM

$ITMN Recent News

6 stocks to watch 3:25 p.m. May 29, 2014 - The Trading Deck
Charting the Nasdaq’s technical breakout 12:34 p.m. May 27, 2014 - Michael Ashbaugh
Charting the Nasdaq’s technical breakout 12:05 p.m. May 27, 2014 - Michael Ashbaugh
6 stocks to watch 3:25 p.m. May 7, 2014 - The Trading Deck
InterMune slips off lofty perch while Aegerion's earnings disappoint 12:26 p.m. Feb. 26, 2014 - Russ Britt
'Bad' weather heads west, retailers report, and don't short addiction 8:06 a.m. Feb. 26, 2014 - Shawn Langlois
InterMune's big day lifts ETF, biotech index to record highs 5:44 p.m. Feb. 25, 2014 - Russ Britt
InterMune shares more than double on tests for lung-disease treatment 12:27 p.m. Feb. 25, 2014 - Russ Britt
Biogen, InterMune, Alkermes all make stock waves with earnings 2:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 4:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 5:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 10:44 a.m. March 21, 2013 - Russ Britt
Thursday’s biggest movers; Apple at 5-month low 6:27 p.m. Nov. 8, 2012 - Sue Chang
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Stocks to watch Tuesday: Nordson, Georgia Gulf 6:40 a.m. May 22, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:19 p.m. April 9, 2012 - Kate Gibson
InterMune: Light at the end of the tunnel? 3:31 p.m. April 9, 2012 - blogs.marketwatch.com
InterMune tumbles on study update 12:27 p.m. April 9, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining & declining stocks 4:34 p.m. March 15, 2012 - Kate Gibson
InterMune climbs on German regulatory update 12:28 p.m. March 15, 2012 - Val Brickates Kennedy

InterMune Resubmits Esbriet NDA - Analyst Blog 6:18 p.m. May 28, 2014 - Zacks.com
Isis Shines, PTC Therapeutics Soars - Analyst Blog 11:16 a.m. May 28, 2014 - Zacks.com
Intermune resubmits NDA 8:24 a.m. May 27, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ITMN CAB SPWH DKS OPK YHOO 6:00 a.m. May 23, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: What Was Bad Is Good Again 7:54 p.m. May 22, 2014 - TheStreet.com
Additional Data on InterMune's Esbriet - Analyst Blog 5:05 p.m. May 21, 2014 - Zacks.com
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
InterMune Up on Esbriet Data Presentation - Analyst Blog 4:30 p.m. May 20, 2014 - Zacks.com
InterMune Offers Added Pirfenidone Data in Idiopathic Pulmonary Fibrosis, Says Endpoint Was Met with Statistical Significance in Capacity 2 4:03 p.m. May 20, 2014 - benzinga.com
InterMune (ITMN) Jumps: Stock Moves 13.4% Higher - Tale of the Tape 9:25 a.m. May 20, 2014 - Zacks.com
Why InterMune (ITMN) Stock Surged to a One-Year High Today 2:16 p.m. May 19, 2014 - TheStreet.com
Jim Cramer's Stop Trading: InterMune Shoots Higher, Zillow Could Too 11:15 a.m. May 19, 2014 - TheStreet.com
UPDATE: Investors Bullish On InterMune After Leerlink Upgrade 10:50 a.m. May 19, 2014 - benzinga.com
InterMune Higher on Superior Lung Drug Data, FDA Resubmission Next 10:39 a.m. May 19, 2014 - TheStreet.com
Benzinga's Volume Movers 9:27 a.m. May 19, 2014 - benzinga.com
Will This Analyst Upgrade Help InterMune (ITMN) Stock Today? 9:20 a.m. May 19, 2014 - TheStreet.com
Morning Market Movers 8:45 a.m. May 19, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. May 19, 2014 - benzinga.com
Pirfenidone Phase 3 achieves primary endpoint 10:53 p.m. May 18, 2014 - Seeking Alpha
Lung Drug Data Showdown: InterMune vs. Boehringer Ingelheim 5:05 p.m. May 18, 2014 - TheStreet.com

Critical Alerts For Macy's, Western Digital, InterMune, Merck, and Time Warner Released By InvestorsObserver 9:31 a.m. May 28, 2014 - PR Newswire - PRF
InterMune Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF 7:00 a.m. May 27, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary Fibrosis 5:00 p.m. May 20, 2014 - PR Newswire - PRF
Morning Coverage of Equities Reaching New Highs -- Research on InterMune, Zillow, ICICI Bank, and Zendesk 11:14 a.m. May 20, 2014 - PR Newswire - PRF
Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine 5:02 p.m. May 18, 2014 - PR Newswire - PRF
IDIOPATHIC PULMONARY FIBROSIS PATIENTS TO HAVE EXPANDED ACCESS TO THERAPY 8:12 a.m. May 16, 2014 - GlobeNewswire
InterMune Announces Expanded Access Program for Pirfenidone to Treat Idiopathic Pulmonary Fibrosis (IPF) in the United States 8:00 a.m. May 16, 2014 - PR Newswire - PRF
InterMune Announces Upcoming Data Presentations at 2014 American Thoracic Society Meeting 8:00 a.m. May 12, 2014 - PR Newswire - PRF
InterMune Reports First Quarter 2014 Financial Results, Clinical Development and Business Highlights 4:01 p.m. May 1, 2014 - PR Newswire - PRF
InterMune To Release First Quarter Financial Results On May 1 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Approved Equities, Voluntary Recall, and New Product Launches - Analyst Notes on Baxter, Agilent, InterMune, Intuitive Surgical, and Mindray 8:00 a.m. March 14, 2014 - PR Newswire - PRF
InterMune Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock 7:20 p.m. March 13, 2014 - PR Newswire - PRF
InterMune Announces Proposed Public Offering of Common Stock 4:02 p.m. March 12, 2014 - PR Newswire - PRF
Top Gainers under the Lens: Advanced Micro Devices, Big Lots, InterMune, and Palo Alto Networks 1:38 p.m. March 10, 2014 - PR Newswire - PRF
Cannabis & Biotech Advancers Forging Ahead - Company Contracts With One of The Oldest Marijuana Dispensaries in California 9:05 a.m. March 10, 2014 - PR Newswire - PRF
Critical Alerts For InterMune, Infinity Pharmaceuticals, Zulily, Intrexon, and Polypore International Released By InvestorsObserver 10:31 a.m. Feb. 26, 2014 - PR Newswire - PRF
Consensus Earnings Forecast for BlackBerry, AT&T, Micron, InterMune, RF Micro Devices, and Coca-Cola 10:00 a.m. Feb. 26, 2014 - PR Newswire - PRF
Office Depot Offers Disappointing Outlook; InterMune Soars 170% to Record High on Phase 3 Test Results 1:25 a.m. Feb. 26, 2014 - ACCESSWIRE
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF) 8:00 a.m. Feb. 25, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LaserPecker Debuts U1: Innovations in UV Laser Engraving

An Eye on the Future with LaserPecker's U1 This ain't your typical innovation announcement. LaserPecker is shifting the sands with their latest release, the U1, at IFA 2026 in Berlin. For anyone sick of struggling with transparent materials like glass and crystal, this thing promises to be a game-changer, boasting cutting-edge technology in UV laser engraving. While...

TCL CSOT Dazzles IFA 2026 with Future Display Tech

Breaking Ground in Display Technology Picture this: the bustling halls of IFA 2026 in Berlin, teeming with tech enthusiasts and industry leaders. Today marks the start of the grand event where TCL CSOT steps into the spotlight, unveiling a stunning array of next-gen display technologies under the APEX brand. This isn't just another tech show-and-tell; it's TCL’s bold...

Clinical Trials Services Market Set for Big Growth

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

AARP New York Promotes Affordable 'Staycation' Experiences

Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...

AI Data Retention: FastGPT’s Detailed Deletion Protocols

In the world of AI-driven applications, data retention has become a hot potato, especially when we're talking about sensitive information like conversation records and audit logs. FastGPT, an open-source AI platform, has decided to tell it like it is by detailing exactly how these data pieces are retained and ultimately booted out. All this info was scattered to the winds...

Ramaco Resources Faces Stock Shake-Up Amid Distribution

Stock Shake-Up In The Coal Industry Something's brewing in the coal mines of West Virginia, and it isn't just the usual dust settling. Ramaco Resources, Inc. (NASDAQ: METC), the metallurgical coal titan, is feeling the heat from some unexpected stock market turbulence, and it's got everyone in the investment trenches scratching their heads. The Yorktown Energy Partners'...

Art and Science Blend in Dr. De La Cruz's Approach

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

TECNO POVA 8 Pro 5G: Blending Speed with Style

TECNO's Newest Launch: A Marriage of Luxurious Design and Performance This ain't just any phone—they've hitched a race car to your pocket. The TECNO POVA 8 Pro 5G Tonino Lamborghini Limited Edition makes a splash, promising to redefine what folks expect from a luxury-tier device, thanks to its endorsed partnership with the iconic Italian brand. But what's all this mean...

Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...